Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Convincing results: Stopping the spread of cancer in the body

22.11.2004


A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body. The discovery may also help reduce the amount of chemotherapy used.



The discovery, which was recently published in the prestigious International Journal of Cancer, was made by a research team from the Finsen Laboratory at Copenhagen University Hospital – Rigshospitalet and the Institute of Molecular Biology at the University of Copenhagen. “What is special about the enzyme – urokinase plasminogen activator (uPA) – is that the cancer needs the enzyme in order to spread throughout the body, but the body does not need the enzyme to function normally. This means that we should be able to block the enzyme and thereby check the spread of the cancer without causing the strong side effects for the patients that we see with other forms of therapy today,” says Morten Johnsen, Institute of Molecular Biology, University of Copenhagen.

“When women discover a lump in their breast, it can be removed. But if the cancer has spread to other parts of the body, such as the lungs, then it can become life-threatening. So we’ve come a long way towards being able to limit the spread of the cancer in the body,” says Kasper Almholt, PhD, Finsen Laboratory.


At K.A.S. Herlev Hospital, doctors are very pleased with the discovery. “The research looks very promising. If the clinical trials also show that it is possible to halt the spread of the tumour, then the research team has found the key to stopping the spread of cancer in the body, which is the cause of most of the deaths among cancer patients today. This is a huge advance in cancer research,” says Torben Skovsgaard, Chief Hospital Physician, Department of Oncology, K.A.S. Herlev Hospital.

Reducing the spread of breast cancer to 1/7

The research findings, which are based on experiments on genetically modified mice, show that the spread of breast cancer in mice that do not have the enzyme is reduced to 1/7. The findings also show that the mice do not suffer in any way from not having the enzyme, i.e. they do not experience any side effects.
The next step is to develop a medication that works on mice. Only then will testing the medication on humans be considered.

Hope for cancer patients

More than 33,000 men and women are diagnosed with cancer every year. With the discovery of this enzyme, the researchers hope to be able to develop in the course of a few years a medication that can prevent the spread of cancer and, thus, reduce the number of deaths among cancer patients.

Associate Prof. Morten Johnsen | alfa
Further information:
http://www.molbio.ku.dk

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>